Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 4Gynecologic 3Other solid neoplasm 2Other hematologic neoplasm 1

Conditions

Pediatric Solid Tumor 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

pembrolizumab 27Pemetrexed 10Nivolumab 10Cyclophosphamide 10Carboplatin 10atezolizumab 8Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6fludarabine 5Injections 5tislelizumab 4spartalizumab 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4sintilimab 3durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Genetic Testing × Other solid neoplasm × Clear all
NCT02520713 2026-04-28

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Dana-Farber Cancer Institute

Active not recruiting
825 enrolled
Other solid neoplasm

Pediatric Solid Tumor

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

City of Hope Medical Center

Phase EARLY_PHASE1 Active not recruiting
100 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡